Shining a light on respiratory tract infections
As respiratory outbreaks, pathogen mutations, emerging pathogens and growing antimicrobial resistance continue, having precise and timely diagnosis is pivotal to curbing transmission, contributing to clinical decision-making and supporting healthcare systems.
Our respiratory portfolio utilizes gold-standard PCR technology, enabling laboratories to automate, conduct multiplex testing and standardize workflows, bringing care closer to the patient.
Roche's diagnostic respiratory portfolio is built on the foundations of quality and efficiency. With almost 30 years of experience in respiratory research, we are dedicated to improving patient outcomes. We work closely with laboratorians to provide them with the necessary diagnostic systems and assays to enable patient care.
Targeted, quick
near patient testing
cobas® liat system
- Results available in 20 minutes or less
- Less than one minute of hands-on time
- Compact footprint and designed to run CLIA-waived assays at the point of care
Flexible, efficient,
and automated testing
cobas® 5800 system
cobas® 6800 system
cobas® 8800 system
- Medium/high-throughput multiplex and singleplex
- Extensive system and assay contamination control measures
- Consolidate with other lab testing
- Minimal hands-on-time and high work-away time
Comprehensive, fast
syndromic testing
cobas® eplex system
- Broad coverage of pathogens (viral, bacterial)
- Easy to use workflow
- Urgent resulting for high-risk patients
Featured products
End of Public Health Emergency
Stay up to date on Roche Diagnostics' efforts regarding the COVID-19 pandemic.